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ttp://dx.doi.org/10.1016/j.ajpath.2012.12.017The process of cellular eating, or the phagocytic swallowing of one cell by another, is an ancient
manifestation of the struggle for life itself. Following the endosymbiotic origin of eukaryotic cells,
increased cellular and then multicellular complexity was accompanied by the emergence of autophagic
mechanisms for self-digestion. Heterophagy and autophagy function not only to protect the nutritive
status of cells, but also as defensive responses against microbial pathogens externally or the ill effects
of damaged proteins and organelles within. Because of the key roles played by phagocytosis and
autophagy in a wide range of acute and chronic human diseases, pathologists have played similarly key
roles in elucidating basic regulatory phases for both processes. Studies in diverse organ systems
(including the brain, liver, kidney, lung, and muscle) have deﬁned key roles for these lysosomal
pathways in infection control, cell death, inﬂammation, cancer, neurodegeneration, and mitochondrial
homeostasis. The literature reviewed here exempliﬁes the role of pathology in deﬁning leading-edge
questions for continued molecular and pathophysiological investigations into all forms of cellular
digestion. (Am J Pathol 2013, 182: 612e622; http://dx.doi.org/10.1016/j.ajpath.2012.12.017)“Life is cell activity; its uniqueness is the uniqueness of the
cell.” eRudolf Virchow1Supported in part by the NIH (AG026389, NS065789, and NS059806
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trainee on T32 HL094295. C.T.C. is recipient of a Julie Martin Mid-Career
Award in Aging Research funded by the Ellison Medical Foundation and
the American Federation for Aging Research.Invitation to a Cellular Banquet
In the 19th century, Rudolph Virchow’s observation that
diseases originate with changes in individual cells gave rise
to the principles of cellular pathology, which remain as
cornerstones of diagnostic medicine to this day. Although
Virchow disagreed with his contemporary Louis Pasteur
concerning the germ theory, he recognized that no single
authority should be considered infallible, and advocated for
active involvement of physicians in experimental pathology.
Indeed, we now know that diseases can be caused both by
invasion of microorganisms and by inappropriate host
responses to them.
The ingestion of one cell by another undoubtedly arose as
a feeding mechanism in unicellular organisms. In a twist of
fate, proteobacteria and cyanobacteria engulfed by larger
archaebacteria managed to survive, giving rise to symbiotic
relationships that form the basis of eukaryotic cells.2 In ourstigative Pathology.
.bodies, professional phagocytes function as a ﬁrst line of
defense against external pathogens, adapting ancient
engulfment mechanisms from unicellular ameboid organ-
isms. (An example of normal phagocytosis of bacteria is
shown in Figure 1.) Likewise, as cells became more
complex, self-cannibalism by autophagy evolved from
a starvation response to fulﬁll additional roles in cellular
homeostasis. These include the defense of the cell against
mitochondrial endosymbionts gone bad or in response to
disorders of proteostasis that threaten the cell from within.
Moreover, autophagy forms another line of defense against
microbial pathogens that can subvert the endocytic/phago-
cytic system to gain entry into the cell.3
It is not surprising, then, to ﬁnd that a wide range of
human diseases are associated with dysfunctional phago-
cytosis or autophagy. Given that both phagocytosis and
Figure 1 Normal phagocytosis of bacteria, demonstrated with immu-
noﬂuorescence. A wild-type, EC-SODeexpressing, peritoneal macrophage
(red) (Invitrogen CellTracker CMRA; Life Technologies, Carlsbad, CA)
exposed to EGFP-expressing E. coli (green) rapidly internalizes several
bacteria.
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logical stimuli, experimental pathologists have played key
roles in deﬁning central themes for investigation since the
1890s, and their ﬁndings often appeared in The American
Journal of Pathology (AJP) or its precursor journals. Using
biochemical, ultrastructural, and ﬂuorescence methods,
pathologists deﬁned key stages in these dynamic processes,
for which detailed molecular mechanisms are still being
unraveled today. More recent studies use molecular
approaches to manipulate disease models, revealing that
either inadequate or excessive cellular eating can contribute
to the pathophysiology of diseases. These studies fore-
shadow current interests in deﬁning speciﬁc macromolec-
ular signaling and adaptor mechanisms that underlie the
physical recognition and sequestration of cargo, the
completeness of their disposal, and future implications for
disease therapy.Phagocytosis Throughout the Last Century
Setting the Table: Early Studies in Phagocytosis
Phagocytosis is an evolutionarily conserved mechanism by
which certain cells engulf and digest other cells or foreign
particles. Ilya (also Élie) Metchnikoff, a Russian zoologist,
ﬁrst described phagocytosis in 1882 after observing that
speciﬁc cells in starﬁsh larvae absorbed thorns from his
tangerine tree.4,5 Over the next few years, Metchnikoff
established that phagocytosis is a conserved defense
mechanism among species, and that it relies on the function
of specialized cells (phagocytes).4,5 His landmark work
earned him the Nobel Prize for Physiology or Medicine in
1908 (shared with the German scientist Paul Ehrlich) and
sparked more than a century of research on the subject.
The earliest articles on phagocytosis sought to deﬁne the
phenomenon: Which cells are active? Where in the body areThe American Journal of Pathology - ajp.amjpathol.orgthey acting? What can these cells ingest? What conditions
trigger phagocytic activity? In 1897, J.L. Goodale6 reported
a study in the Journal of the Boston Society of Medical
Sciences (which later became the Journal of Medical
Research and then the AJP), showing that polynuclear
leukocytes in the tonsillar mucus membrane absorb foreign
matter and proving that specialized cells in the body possess
phagocytic activity against bacteria. In 1906, Buxton and
Torrey7 reported for the ﬁrst time that macrophages can
engulf foreign animal cells, in addition to bacteria. In that
study they also examined migration patterns of phagocytes
after ingestion of a bacterial load, observing that most of
these cells end up in lymph nodes. Buxton and Torrey found
that resident tissue mononuclear phagocytes (macrophages)
are the initial responders to infection, and that polynuclear
cells (neutrophils) arrive later, to complete the removal of
the invading organism. Finally, they found that non-
digestible particles can remain in phagocytes for months
before eventually being fragmented and released.
The next wave of research followed the landmark 1903
article by Wright and Douglas,8 in which they described
opsonins (molecules in the bloodstream that bind to bacteria
to promote phagocytosis by host cells). Antibodies, opso-
nins, and other substances in body ﬂuids became the focus
of the work of many pathologists in the 1900s and 1910s, as
they worked to understand what regulates phagocytosis.
Destruction of opsonins through heating of blood serum was
found to markedly inhibit the ability of phagocytes to digest
bacteria.9 These ﬁndings also led to studies examining the
role of opsonins in vaccine development.10
In 1917, Bartlett and Ozaki11 reported additional in vivo
studies of phagocytosis. They found that bacteria are rapidly
removed from the blood within minutes after inoculation,
usually by mobile leukocytes. During heavy infection,
however, uptake by mobile phagocytes is insufﬁcient, and the
majority of invading bacteria enter the tissues to be engulfed
by phagocytic cells within the tissue. As foreshadowed by the
study of Buxton and Torrey,7 a large body of research focused
on the migratory patterns of phagocytes in various organs after
ingestion of bacteria, including lung,12 liver,13 spleen,13,14 and
digestive tract.7 In the setting of acute pneumonia, Permar12,15
studied themigration of leukocytes from tissues into interstitial
spaces and eventually into the lymphatic system, where the
cells can reside in lymph nodes for an extended period.
In the 1920s and 1930s, a debate about the cellular origin
of mononuclear phagocytes emerged in the literature.
Scientists struggled to determine whether phagocytic cells
originated from vascular endothelium, epithelium, or blood
monocytes.16e18 Howard Permar19,20 at the University of
Pittsburgh argued that mononuclear phagocytes are formed
from vascular endothelium in amounts proportional to the
number of invading bacteria, and that these numbers are
especially high in blood vessels adjacent to infected and
inﬂamed tissue. Although Permar was correct in noting that
infection triggers increased phagocytic cell production and
phagocyte migration to the site of infection, he was incorrect613
Oczypok et alin his theory about the origin of mononuclear phagocytes. In
1922, Simpson21 proposed that macrophages originate from
monocytes that are released into the blood in bursts, or
showers, during infection. This proposal withstood the test
of time. In 1927, Nathan Chandler Foot22 stated, in an
article in the AJP, that what were then called dust cells in the
lung originated from blood monocytes, not from epithelial
tissue. By the mid-20th century, it was established that
mononuclear phagocytes originate as myeloid cells in the
bone marrow, and that infection triggers release of mono-
cytes into the bloodstream from the bone marrow.23 The
exact cytokine signals causing this release are not yet well
deﬁned. Monocytes extravasate through vascular endothe-
lial cells (which may account for Permar’s conclusions) into
tissue, where they then differentiate into macrophages and
dendritic cells.24
Phagocyte Activation: A Knife That Cuts Both Ways
In the mid-20th century, researchers began to focus on
deﬁning the regulatory crosstalk between phagocytes and
their environment. The complement system was already
known to promote neutrophil chemotaxis, but in 1968 it was
discovered that bacteria themselves secrete substances that
draw neutrophils to the site of infection.25 In a 1976 review in
the AJP, Unanue26 examined interactions between phago-
cytes and their environment during acute and chronic
inﬂammation, wound healing, and normal immune responses.
He not only discussed several chemotactic stimuli, but also
highlighted the importance of surface receptors on the
phagocyte that are necessary for the binding, ingestion, and
degradation of foreign particulates (Figure 2). The following
year, it was found that disorders of recognition and ingestion
of foreign matter by these phagocytic receptors can lead to
clinical pathology.27 Recent studies have conﬁrmed that an
inability to properly complete phagocytosis contributes to
a variety of diseases, including atherosclerosis and autoim-
mune diseases.28,29
That phagocytes are necessary for properwound repair in the
absence of infection was also elucidated in the 1970s. Phago-
cytes were found to be required not only for removal of dead
tissue, but also for communication with ﬁbroblasts, to stimu-
late ﬁbrous scarring.30 Indeed, as Unanue26 noted, phagocytes
secrete a wide array of substances into the environment,
including enzymes (eg, lysozyme, plasminogen activator,
collagenase, and elastase), signals for immune modulation
(eg, lymphocyte recruitment, colony-stimulating factor,
and inhibitory and lytic signals), and complement proteins.
Unanue26 also made the astute observation that some of these
secretions could be harmful to host tissuedan important
concept for chronic inﬂammatory conditions. The pathological
role of phagocytes is perhaps best illustrated in a series of AJP
articles on atherosclerosis that appeared in the 1980s.31e33
Monocytes were identiﬁed as the precursors to foam cells in
plaques, actively recruiting more inﬂammatory cells to the
lesion and thus promoting growth of atherosclerotic lesions.614In recent decades, much of the work on phagocytosis has
been at the molecular level, with focus on speciﬁc receptors
and molecules that dictate phagocyte behavior.34e37 Iden-
tifying the various roles of phagocytic cells in a variety of
diseases has remained an important area of active investi-
gation, including studies of neurodegeneration,38e41 wound
repair,42 and cancer.43 Indeed, more recent studies have
focused on different classes of macrophages involved in
inﬂammatory responses [currently, these are simpliﬁed as
classically activated M1 (proinﬂammatory) and alternatively
activated M2 (tissue remodeling) responses]. A growing
number of recent studies, published in the AJP and else-
where, have shown that inappropriate regulation of the M1/
M2 balance may contribute to the pathogenesis of a number
of diseases, including spinal cord injury,44 sarcoidosis,45
glomerulonephritis,46 and pulmonary ﬁbrosis.47
Frustrated Phagocytosis and Indigestion: Role of
Reactive Oxygen Species
Once a phagocyte has engulfed a pathogen, the immune cell
must be able to kill the bacteria (Figure 2). One method by
which neutrophils and macrophages kill ingested bacteria is
through the respiratory burst, which is initiated via the
NADPH oxidase system. A 1982 review in the AJP under-
scores the role of free radicals in phagocyte bactericidal
activity.48 Superoxide ions released by NADPH oxidase
produce hydrogen peroxide after spontaneous or enzymatic
dismutation. Myeloperoxidase then produces hypochlorous
acid (bleach) from the hydrogen peroxide. This results in
concentrated levels of reactive oxygen species (ROS) within
the phagolysosome that are toxic to bacteria. The respiratory
burst was ﬁrst reported in 1933, by Baldridge and Gerard,49
but it was not until the 1960s and 1970s that its role in
bacterial killing was understood.50 The discovery of impaired
activity of the NADPH oxidase enzyme (and thus no
oxidative burst) in chronic granulomatous disease high-
lighted the importance of the respiratory burst in immunity.
Patients with chronic granulomatous disease are at a high risk
of developing chronic and recurring infections, especially
abscesses and pneumonia; even though their phagocytes can
ingest invading bacteria, they cannot efﬁciently complete the
killing of these bacteria within their phagolysosomes.
Although ROS production by phagocytic cells plays
a crucial role in bacterial killing, overproduction of these
molecules during inﬂammation can also damage host
tissues. Oxidant levels must, therefore, be tightly regulated
in the body. A vast antioxidant system is present in normal
tissues and within phagocytes themselves, to protect against
oxidative damage.48
Importantly, phagocytosis itself can be impaired by
a failure to appropriately regulate oxidant levels in the body,
as shown in a 2011 AJP report of a study in mice lacking the
antioxidant enzyme extracellular superoxide dismutase (EC-
SOD).51 The data showed that EC-SOD is localized inside
macrophage and neutrophil granules. Whereas wild-typeajp.amjpathol.org - The American Journal of Pathology
Figure 2 Major steps in phagocytosis and
autophagy. The proper induction (A and B), cargo
targeting (C), maturation (D and E), and completion
of lysosomal clearance (F) are all important for both
phagocytosis and autophagy. For phagocytosis, the
recognition of danger signals from dead cells or
microbial pathogens stimulates phagocyte migra-
tion. A number of different receptors are involved in
capturing and internalizing bacterial, apoptotic, or
particulate cargoes through a process enhanced by
Atg proteins and dependent on a proper local redox
environment maintained by EC-SOD. Once the
phagocytic cargo is inside the phagosome, concen-
trated production of ROS or degradative enzymes are
stimulated, depending on the ingested contents.
Similarly, either general or localized insults within
cells serve to trigger themembrane deposition of Atg
5dAtg 12 and of LC3 (through Beclin 1edependent
or independent mechanisms), which are essential for
the extension of autophagic membranes. Whereas
nonselective sequestration of cytoplasm is induced
by starvation, damaged and potentially harmful
cargoes need to be appropriately targeted to LC3-
bound membranes. Autophagy is also induced by
phagosome-derived signals to sequester pathogens
that escape or damage the phagosomemembrane. In
turn, induction of the autophagic pathway serves to
further promote phagosomeelysosomal fusion.
Thus, these two complementary systems cooperate
in removing exogenous and endogenous danger
signals to limit proinﬂammatory, carcinogenic, and
prodeath stimuli. For both phagocytic and auto-
phagic pathways, inefﬁcient lysosomal fusion or
digestion can contribute to many classes of disease
(red-shaded boxes). Accumulation of undigested
lysosomal cargo is seen in aging and in chronic
granulomatous disease (CGD), neurodegenerative
diseases, and many other diseases or disorders.
Inefﬁcient utilization of digested products for
energy production or in the regeneration of mito-
chondria and other essential cellular structures may
also contribute to cell death and neurodegeneration.
ASIP Centennial ReviewEC-SOD expressing macrophages undergo efﬁcient bacte-
rial phagocytosis (Figure 1), phagocytosis is markedly
impaired in EC-SOD knockout macrophages (not illus-
trated).3 This suggests that ROS production by phagocytic
cells can disrupt normal phagocytosis if EC-SOD is not
present to protect the phagocyte itself from its own
production of ROS. This ﬁnding further illustrates the
importance of regulating ROS production, even in settings
where large quantities of ROS are physiologically produced
for bactericidal activity. The targets through which excess
superoxide or downstream ROS interfere with phagocytosis
are unclear, but this study highlights an important role for
EC-SOD in phagocytic cells in promoting appropriate
innate immune responses to bacterial pathogens.51
The antioxidant regulation of ROS production is also
important for maintaining effective phagocytic function at
later stages of bacterial killing, as highlighted in a study of
the intracellular pathogen Mycobacterium abscessus.52 This
study found that antioxidants promote killing of theThe American Journal of Pathology - ajp.amjpathol.orgmycobacteria by promoting phagosomeelysosome fusion.
Thus, regulation of ROS production in phagocytic cells
appears to be essential not only in the maintenance of
normal phagocytic uptake of bacteria51 but also in
promoting the phagosomeelysosome fusion needed for
completion of bacterial killing.52
The redox environment within the phagosome is impor-
tant also for adaptive immune responses. Proteolysis within
the phagosome allows macrophages to degrade pathogen
proteins in preparation for antigen presentation. NADPH
oxidase activity during the respiratory burst was recently
shown to reversibly oxidize cysteine residues in some
cathepsins, which the authors propose may alter the reper-
toire of antigenic peptides produced.53 Additionally, ROS
release from phagocytes has been shown to activate NF-
kB,54 a transcription factor involved in promoting both
innate and adaptive immune responses. These ﬁndings
indicate that, even during a respiratory burst generated for
bacterial killing, tight regulation by antioxidants is615
Oczypok et alimportant for enhancing the overall efﬁciency of phagocytic
functions.
Macroautophagy: Six Decades of Progress
Hors d’Oeuvre: Early Studies in Autophagy
The biochemical discovery of lysosomes (specialized in-
tracellular compartments devoted to hydrolytic digestion) by
Christian de Duve and colleagues55 coincided with patho-
logical studies of cytoplasmic inclusions reported by H.W.
Altmann in 1955. Altmann (as cited by Hruban et al56)
speculated that certain inclusions represent a stage in the
cellular reaction to injury in which damaged portions of
cytoplasm are sequestered for digestion or extrusion. This
process of localized cellular digestion represents the
deﬁning feature of macroautophagy. Moreover, mechanisms
underlying autophagy-related cellular exocytosis, as pre-
dicted by this study more than 50 years ago, have recently
been described.57,58
In 1963, in one of the ﬁrst experimental studies of auto-
phagy reported in the AJP, Z. Hruban et al56 recognized
a continuum of structures reﬂective of what they deﬁned as
a single dynamic process, outlining three progressive stages
for focal cytoplasmic degradation: i) sequestration, ii)
formation of complex bodies, and iii) formation of
lysosome-like bodies (Figure 2). This study, which involved
systemic treatment of rats with an array of stressors fol-
lowed by ultrastructural examination of liver cells revealed
that the contents inside of autophagosomes depends on the
nature of the insult. Furthermore, the authors noted that
focal cytoplasmic degradation is not limited to pathological
states, but occurs also under physiological conditions “for
disposal of organelles when the cell changes its functional
state.” These observations, made before the term autophagy
came into use, laid the foundation for current studies of
autophagic ﬂux and selective autophagy in differentiation
and disease.
In 1968, Antti Arstila and Benjamin Trump59 reported
another landmark study, which remains the second most cited
autophagy study, after that of Hruban, published in the AJP
(Thompson Reuters Web of Science version 5.9, last accessed
January 29, 2013). In this study, they addressed a set of
important questions for cellular autophagocytosis. These
questions relate to the origin or origins of the hydrolytic
enzymes, the origin or origins of the enclosing autophagic
membrane, and “the control mechanisms and metabolic
requirements involved in autophagy.” Using density gradient
fractions and histochemical techniques to visualize enzyme
activity by transmission electron microscopy, they showed
that the double membrane phase of autophagosomes lacked
hydrolytic enzymes, but exhibited features of smooth endo-
plasmic reticulum. Fusion of the autophagosome outer
membrane with vesicles containing hydrolytic enzymes
resulted in delivery of enzyme to the space between the double
limiting membranes, which was followed by loss of the inner616membrane. The fusion process required “high energy
compounds,” but not protein synthesis. This was followed by
a series of studies in the 1970s by Shelburne, Arstila, and/or
Trump deﬁning the roles of cAMP, protein synthesis, nutritive
status, and energy metabolism in hepatocyte, renal tubules,
and HeLa cells (for example, Shelburne et al60). An early
description of selective mitophagy elicited in renal tubules by
hyperbaric oxygen exposure was published in the AJP in
1979,61 nearly 30 years before this would re-emerge as
a central topic in autosomal recessive Parkinson’s disease.62,63
In a similar time period, the occurrence of autophagy was
delineated in several systemsof cell death, both developmental
and injurious (reviewed by Bursch64). Indeed, three charac-
teristic morphological patterns of cell death were deﬁned: i)
shrinkage necrosis, which is now known as apoptosis, ii) the
controversial autophagic cell death, or cell death accompanied
by autophagosomes, and iii) necrotic cell death, which is
characterized by organelle swelling and loss of membrane
integrity. Nonetheless, the role or roles of autophagy in cell
degeneration and death (whether beneﬁcial, maladaptive,
coincidental, or part of an active cell death program) would
remain inscrutable until the discovery of autophagy-related
(Atg) genes and proteins in the years surrounding the turn of
the millennium (reviewed by Klionsky et al65).
Autophagy in Diseases: Cytoprotection versus
Gluttony?
In the 1980s and 1990s, autophagolysosomal processes
were identiﬁed in association with characteristic cytopa-
thologic hallmarks of several human diseases. These include
the rimmed vacuoles of certain forms of myopathy,66 and
granulovacuolar degeneration in hippocampal neurons of
patients with Alzheimer disease.67 These authors proposed
that autophagy was activated as a means of protective
sequestration against early apoptotic changes, expanding on
the concepts advanced by Altmann and by Hruban.56
Indeed, a recent study of autolysosomal pathology in Alz-
heimer disease, by Ralph Nixon and colleagues, 68 revealed
a mechanism by which autophagy protects against apoptosis
through degradation of activated caspase-3 in dystrophic
neurites. Likewise, clearance of damaged mitochondria by
autophagy serves a neuroprotective role in a PTEN-induced
kinase 1 (PINK1)edeﬁcient recessive model of Parkinson’s
disease.63 Protective or compensatory roles for autophagy
were also delineated in acute injury models and sepsis.69,70
In analogy to the ﬁeld of apoptosis after the identiﬁcation
of Bcl-2 as a survival oncogene in 1989,71 the identiﬁcation
of conserved autophagy genes beginning a decade later
triggered a surge of interest in the role of autophagy in
physiology and disease, and this interest continues to grow
exponentially. In particular, the delineation in 2000 of
a ubiquitin-like conjugation event involving Atg8/microtu-
bule associated protein-1 light chain 3 (LC3), which is
essential for the extension of autophagic membranes,72,73
provided molecular tools for monitoring autophagosomesajp.amjpathol.org - The American Journal of Pathology
ASIP Centennial Reviewand for manipulating autophagy induction. A landmark
study in 2004 demonstrated the therapeutic potential for
autophagy in animal models of Huntington’s disease.74 This
has been followed by reports indicating protective effects of
autophagy-enhancing drugs in other protein aggregation
diseases.75,76 The concept of autophagy as a key clearance
mechanism for pathological protein inclusions in turn
inspired investigations into mechanisms underlying selec-
tive cargo recognition, resulting in the discovery of p62 and
other LC3-interacting proteins as molecular adaptors for
ubiquitin-coated protein aggregates.77
The prospect of harnessing autophagy-related clearance
mechanisms for various human diseases, and potentially in
slowing the process of aging itself, has engendered much
excitement. Our understanding of the network of regulatory
mechanisms that affect induction and completion of auto-
phagy, not to mention its crosstalk with biosynthetic and
other stress responses, has been growing rapidly, but has
also stimulated further questions that remain to be answered.
For example, the ability to therapeutically upregulate auto-
phagy by rapamycin may be limited by metabolic distur-
bances associated with the chronic complex I deﬁciency
observed in Parkinson’s patients.78 This and other articles
published in the AJP in the ﬁrst decade of the 21st century
have pioneered several key considerations concerning the
biology of autophagy in the context of disease.
In 2007, the fourth and ﬁfth most cited autophagy articles in
the AJP linked autophagy to the outcome of endoplasmic
reticulum stress in cancer cells79 and deﬁned a role for non-
canonical beclin 1eindependent autophagy in cell death
(discussed in the following paragraph).80 In the former study,
Xiao-Ming Yin and colleagues79 showed that proteasome
inhibition activated autophagy as a compensatory mechanism
through the IRE1-JNK signaling arm of the unfolded protein
response. Subsequent studies implicate the unfolded protein
response in several other disease states to include pretangle
neurons in postmortem Alzheimer disease specimens81 and
muscle biopsies of sporadic inclusion-body myositis.82 An
amplifying cycle is proposed in which endoplasmic reticulum
stress impairs cathepsin function,82 causing autophagic stress,
deﬁned as an imbalance of autophagy induction and comple-
tion.83 Cathepsin deﬁciency itself causes cellular pathology
similar to that observed in human neuronal ceroid lip-
ofuscinoses,84 and induction of autophagy may prove harmful
in the context of lysosomal dysfunction.85,86
Thecontext-dependent outcomeof autophagy is a central area
for disease pathophysiology and therapy. Also in 2007, a novel
pathwayof autophagy/mitophagywasdescribed in toxin-treated
neuronal cells, which used only a subset of the canonical Atg
proteins that had been deﬁned for starvation-induced auto-
phagy.80Beclin 1/PI3Keindependent autophagy has since been
shown in a growing number of pathological situations.87e89
Given that the prosurvival protein Bcl-2 binds Beclin 1 to
limit its autophagy-related function,90 Beclin 1eindependent
autophagy most likely represents an escape from this important
rheostat function. Indeed, siRNA knockdown of autophagyThe American Journal of Pathology - ajp.amjpathol.orgmediators results in reduced cell death.80,87 Like inﬂammation,
autophagy mediates beneﬁcial responses when it is activated
transiently with appropriate clearance of intermediates, but may
convert to a maladaptive response with excessive or sustained
demands that interfere with completion of the autophagic
response (Figure 2).
Although it may be difﬁcult for researchers studying phys-
iologically regulated autophagy in otherwise normal cells to
envision excessive autophagy induction, data are emerging to
put into context examples of these situations in ailing cells. In
disease models, impairment in microtubule or lysosomal
function results in inefﬁcient clearance of autophago-
somes.91,92 In this context, tuning down the capacity for
autophagy induction by siRNA knockdown of key proteins
would serve to reduce autophagic stress. Aging or diseased
cells may also show declining capacities for regenerative
biosynthesis. For example, excessive ERK1/2 activation drives
mitophagy93 while concurrently suppressing mitochondrial
biogenesis.94 The resulting cataboliceanabolic imbalance
leads to an uncompensated loss of mitochondria, which is
poorly tolerated in neurons and other mitochondria-dependent
cell types. Aberrant ERK1/2 activation has also been impli-
cated in the autophagic degeneration of arsenite-injured renal
tubular cells.95 For the most part, these examples of harmful
autophagy are limited to cell culture systems, which are readily
manipulated in a controlled fashion. Exceptions include the
murine central nervous system. Although a complete loss of
constitutive autophagy is harmful to subsets of neurons,96
suppression of injury-induced autophagy through conditional
deletion of Atg7 has been shown to mediate neuroprotection
in vivo against neonatal ischemiaereperfusion injury and acute
nigrostriatal injuries in mice.97,98
These ﬁndings likely reﬂect a greater demand of neurons
for precise bioenergetic homeostasis, compared with other
glycolytic or proliferative cell types. In several disease
models, autophagosomes are unusually enriched in dendritic
and axonal processes, and these changes appear early in the
course of injury.99 Although insufﬁcient autophagy induc-
tion and completion have each been implicated in axonal
degeneration,96,100 autophagy also degrades receptors and
other important synaptic components.101,102 The subsequent
decrease in function may play into early stages of disease
pathophysiology. Mitochondrial distribution is critically
important to the development and maintenance of synaptic
contacts,103 and a recent article in AJP showing dendritic
mitophagy in a model of Parkinson’s disease reveals another
mechanism by which autophagy can affect neuronal func-
tion. In that study, mitophagy induced as a response to
calcium dysregulation, contributes to the degeneration of
dendrites in neurons expressing mutant forms of leucine-
rich repeat kinase 2.104
Shared Features of Cellular Consumption
Autophagy and phagocytosis probably each began as
a method of promoting cellular nutrition; however, both617
Oczypok et alprocesses have evolved to become key players in cellular
homeostasis and defense against pathogens. Thus, both self-
eating and the consumption of other cells, living or dead,
play key roles in cell survival and tissue homeostasis.
Autophagy and phagocytosis are often upregulated
concurrently with apoptosis. In some contexts, autophagy
serves to prevent apoptosis,105 as in sequestration of damaged
mitochondria that could release death mediators.63,69 On the
other hand, autophagy is often associated with tumor-
suppressing pathways,106,107 and autophagy (or its key
regulatory proteins) may be essential for promoting subse-
quent cell death.95,97 Likewise, phagocytosis is engaged not
only by professional phagocytes to kill living (microbial) cells
or to scavenge necrotic tissue, but also comprises a key
mechanism by which epithelial cells can eliminate the
apoptotic corpses of neighboring cells.108 In this way, danger
signals that may trigger sustained inﬂammation, tissue
ﬁbrosis, allergies, or inﬂammatory carcinogenesis can be
eliminated.109e112
Although autophagy and phagocytosis are activated by
different mechanisms, their ﬁnal steps converge on similar
pathways that are regulated by sharedmolecules. For example,
phosphatidylinositol-3-phosphate (PI3P) is required for both
phagosome and autophagosome generation and subsequent
fusion with the lysosome.113,114 Recent studies, discussed
below, have further highlighted the crosstalk between auto-
phagy and phagocytosis in the clearance of dead cells
(homeostasis) and the destruction of pathogens (defense).
A Well-Balanced Diet: Autophagy and Phagocytosis in
Homeostasis
Rapid and efﬁcient clearing of apoptotic and necrotic cells is
a crucial housekeeping function in the body. Without clear-
ance of dead cells, there is inadequate room for growth of new
cells, and the dead cells release inﬂammatory danger signals
that can be harmful to host tissue. Dead cells that persist in
tissue increase the risk for autoimmune diseases such as
systemic lupus erythematosus,28,115 as well as other morbid-
ities.29 Recent studies show that autophagy and phagocytosis
work together to reduce the volume of dying cells, preventing
the harmful release of inﬂammatory mediators.
Cells that have undergone apoptosis display phosphati-
dylserine on their surface, ﬂagging them for macrophage
ingestion. Macrophages secrete a protein called the milk fat
globule epidermal growth factor 8 (MFG-E8), which binds
to phosphatidylserine and promotes phagocytosis of
apoptotic cells, much like the opsonins ﬁrst described in
1903 by Wright and Douglas8 in bacterial infections. A
recent study by Qu et al116 described the necessity of the
autophagy genes ATG5 or BECN1 for the proper display of
phosphatidylserine eat-me signals on apoptotic cells. The
authors showed that, without proper autophagic function,
phagocytes could not efﬁciently engulf dead cells in
embryoid bodies, leading to developmental abnormalities.
Likewise, autophagy regulated by the Toll-like receptor 4618may be protective in a model of pulmonary ﬁbrosis by
facilitating the clearance of injured or dead cells,117 thereby
accelerating the resolution of inﬂammation.
Uninvited Dinner Guests: Autophagy and Phagocytosis
in Pathogen Clearance
When phagocytosis fails to eliminate a pathogen, autophagy
can act as a back-up system to ﬁght off infection. Certain
bacteria, when phagocytosed, can persist within the phag-
osome or can damage the phagosome to be released into the
intracellular environment. Modiﬁcations or damage to the
phagosome are thought to activate the autophagic machinery.
For example, Listeria monocytogenes bacteria secrete
listeriolysin-O, which lyses the phagosome to release
phagocytosed bacteria, but can also stimulate autophagy.3
Salmonella enterica enterica, serovar Typhimurium, resides
within the phagosome for protection; however, it secretes
proteins as part of its type III secretion system, which trigger
autophagy of the entire salmonella-containing vesicle.3
Additionally, Mycobacterium tuberculosis inhibits phag-
osome maturation, but activation of autophagy is sufﬁcient to
override these effects, resulting in decreased phagosome pH
and restoration of bacterial killing.118 Following Toll-like
receptor signaling on macrophages during phagocytosis,119
LC3 recruitment to phagosomes serves to promote phag-
osomeelysosome fusion to aid in bacterial killing. Despite
these dual mechanisms of phagocytic and autophagic
immune surveillance, pathogens such as hepatitis C viruses
have evolved mechanisms by which they can avoid clearance
by interfering with autophagosomeelysosomal fusion, as
was demonstrated in a study of human liver biopsies reported
in the AJP in 2011.120
Tomorrow’s Menu: Future Themes for Investigation
As we celebrate the Centennial Anniversary of the Amer-
ican Society for Investigative Pathology, it is clear that
central advances in deﬁning and answering key questions in
basic phagocytosis and autophagy research have been made
in the context of tissue injury, repair, and disease by
investigative pathologists using biochemical, morpholog-
ical, and molecular approaches. Future studies in phagocy-
tosis will likely involve continued identiﬁcation of speciﬁc
receptor targets for immunomodulation therapy in a variety
of diseases involving phagocytosis.
Likewise, given the double-edged nature of autophagic
responses, a better understanding of molecular interac-
tions that underlie the selective recognition of damaged
cargo may allow development of therapies to clear
damaged cellular constituents while avoiding bystander
effects. Although the autophagy response is induced in
a wide array of developmental, physiological, and path-
ological situations, the outcome of autophagy induction is
far from uniform. Future studies in aging and diseased
tissues will serve to more fully delineate the cell type- orajp.amjpathol.org - The American Journal of Pathology
ASIP Centennial Reviewstimulus-speciﬁc mechanisms that determine cell fate
after autophagy. It is likely that the outcome will depend
on a balance of several factors.
Finally, given the convergence of autophagic, phagocytic,
and endocytic pathways at the lysosome, a more detailed
understanding of the cellular signaling events that induce
cytoskeletal rearrangements and regulate lysosomal fusion
and activity is of primary importance. Impairments in
completing the process of autophagic degradation, microbial
killing, or clearance of danger signals from damaged cells
undoubtedly play major roles in human diseases. Under-
standing the factors that regulate fusion of phagosomes and
autophagosomes with lysosomes may yield insight into
mechanisms by which some pathogens evade lysosomal
killing. Likewise, efforts to enhance the autophagic degra-
dation of aggregate-prone proteins within the lysosome will
likely prove beneﬁcial for treatment of neurodegeneration
and other diseases of disordered proteostasis.
Ultimately, disease therapies harnessing the power of
phagocytosis or autophagy will likely be dependent on three
factors: i) the ability to correctly target cargo by the phag-
osome or autophagosome, ii) successful intracellular traf-
ﬁcking and lysosomal delivery, and iii) the capacity for
generating germicidal ROS bursts or hydrolytic enzyme
activity to complete the process of lysosomal clearance. As
either a cellular recycling or a defensive response, impair-
ment at any step of the autophagic processdat sequestration
and cargo targeting, at lysosomal fusion and degradation, or
at reutilization of liberated products to replace digested
partsdmay represent potential future targets for disease-
modulating therapies.
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